BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P3D
REFRESH-INTERVAL:P3D
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210120
DTEND;VALUE=DATE:20210121
TRANSP:TRANSPARENT
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE
SUMMARY:A2Y Chamber Event: Virtual Early Edition - January 2021
DESCRIPTION:State of the Biosciences Industry Perspectives from Area Leaders\n\nMichigan's biosciences industry\, and especially the local Ann Arbor region\, has evolved strongly in recent years. This is thanks to a health-care industry desperate for cost-saving innovation\, as well as a supportive ecosystem with great research universities\, skilled talent\, and focus on commercialization. Industry leaders will talk about their companies' growth and what it'll take to ensure an even brighter future for the state's bio-industry. \n\n \n\nPanelists\n\n \n\nStephen Rapundalo\, PhD\, President and CEO\, MichBio\n\n\n\nTim Mayleben\, President and CEO\, Esperion Therapeutics\n\n\n\nScott Merz\, President and CEO\, MC3 Cardiopulmonary\n\n\nBrandon H. McNaughton\, PhD\, Chief Executive Officer and Co-Founder\, Akadeum Life Sciences
X-ALT-DESC;FMTTYPE=text/html:State of the Biosciences Industry &ndash\; Perspectives from Area Leaders
\nMichigan&rsquo\;s biosciences industry\, and especially the local Ann Arbor region\, has evolved strongly in recent years. \;This is thanks to a health-care industry desperate for cost-saving innovation\, as well as a supportive ecosystem with great research universities\, skilled talent\, and focus on commercialization. Industry leaders will talk about their companies&rsquo\; growth and what it&rsquo\;ll take to ensure an even brighter future for the state&rsquo\;s bio-industry.
\n \;
\nPanelists
\n \;
\nStephen Rapundalo\, PhD\, \;President and CEO\, \;MichBio
\n
\nTim Mayleben\, \;President and CEO\, \;Esperion Therapeutics
\n
\nScott Merz\, \;President and CEO\, \;MC3 Cardiopulmonary
\n\n